Effect of active sub-fraction of Ichnocarpus frutescens (L.) R.Br. in the management of obesity.

J Ethnopharmacol

Division of Ethnopharmacology, Entomology Research Institute, Loyola College, Chennai, Tamil Nadu 600034, India; Visiting Professor Programme, Deanship of Scientific Research, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. Electronic address:

Published: January 2016

Aim Of The Study: Ichnocarpus frutescens (L.) R.Br. (Apocynaceae) is used by the traditional healers in India to treat diabetes and hyperlipidemia.This work aims to study the antiobesity effect of the active sub-fraction obtained from the leaves of this plant using in vitro and in vivo models.

Methodology: Active sub-fraction (Sfr3) isolated by column chromatography was analyzed using Gas chromatography and mass spectrometry. Adipogenesis and apoptosis were detected by oil red O and Hoechst-33342 staining, respectively, in 3T3-L1 adipocytes. Expression of specific marker genes involved in lipid metabolism was detected by Reverse Transcriptase Polymerase Chain Reaction in 3T3-L1 adipocytes and adipose tissues of C57 BL/6J mice, fed with high fat diet (HFD) and treated with Sfr3 and fenofibrate for 45 days.

Results: The treatment with Sfr3 decreased lipid accumulation and caused apoptosis in adipocytes. In the HFD induced obese animals, serum and liver lipid levels were decreased and a significant decrease in body weight gain was observed dose dependently in 45 days treatment. Histopathological examination showed decrease in adipose mass and liver lipid accumulation. The effect of Sfr3 on the marker genes of adipocytes was significantly regulated at the treated doses both in vitro and in vivo.

Conclusion: Sfr3 of Ichnocarpus frutescens is effective in the management of obesity through adipocyte apoptosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2015.11.031DOI Listing

Publication Analysis

Top Keywords

active sub-fraction
12
ichnocarpus frutescens
12
frutescens rbr
8
management obesity
8
3t3-l1 adipocytes
8
marker genes
8
lipid accumulation
8
liver lipid
8
sfr3
5
sub-fraction ichnocarpus
4

Similar Publications

and hybrid approach to unveil triterpenoids from leaves as potential compounds for inhibiting Nrf2.

RSC Adv

January 2025

Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University No. 100, Shih-Chuan 1st Road, Sanmin District Kaohsiung City 80708 Taiwan.

Cancer is a leading global health concern, with over 20 million new cases and 9.7 million deaths reported in 2022. Chemotherapy remains a widely used treatment, but drug resistance, which affects up to 90% of treatment outcomes, significantly hampers its effectiveness.

View Article and Find Full Text PDF

Background: Artemisia argyi is a well-known medicinal plant. A. argyi has been widely used in clinical for about 3000 years, owing to its extensive pharmacological activity.

View Article and Find Full Text PDF

The research aimed to determine the inhibitory effects of different fractions of on α-glucosidase, α-amylase, glucose uptake, and Glut-4 expression in 3T3-L1 adipocytes and identification of the active principle. The crude aqueous extract was sequentially sub-fractionated using preparative HPLC and subjected to assays. Fraction 1 (F1) exhibited effective inhibition of both α-glucosidase and α-amylase with an IC value of 90.

View Article and Find Full Text PDF

Despite being a global public health problem, there are no antiviral agents for dengue. Plants are the sources of most approved drugs and many phytochemicals have exhibited in vitro antiviral activity. We explored the antiviral potential of the aqueous extract of Glycyrrhiza glabra roots (GGaq) on dengue viruses.

View Article and Find Full Text PDF

Unveiling the potential of medicinal herbs as the source for screening toward the inhibition of Nrf2.

Heliyon

October 2024

Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, No.100, Shih-Chuan 1st Road, Sanmin District, Kaohsiung City, 80708, Taiwan.

Background: Drug resistance is one of the leading causes attributed to the failure of cancer treatment by chemotherapy. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor regulating gene expression in cell defense against oxidative stress or hazardous factors. Taking advantage of this feature, Nrf2 also serves as the bodyguard for both normal and cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!